Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.
Fiche publication
Date publication
avril 2023
Journal
Progress in neuro-psychopharmacology & biological psychiatry
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel
Tous les auteurs :
Fond G, Faugere M, Boyer L, Peri P, Stephan F, Moliere F, Anguill L, Bennabi D, Haffen E, Bouvard A, Walter M, Samalin L, Llorca PM, Genty JB, Leboyer M, Holtzmann J, Nguon AS, Rey R, Horn M, Vaiva G, Hennion V, Etain B, El-Hage W, Camus V, Courtet P, Aouizerate B, Yrondi A, Lancon C, Richieri R
Lien Pubmed
Résumé
Benzodiazepine long-term use (BLTU) is a public health challenge. We lack data on the consequences of LBTU on the trajectory of treatment-resistant depression (TRD).
Mots clés
Addiction, Benzodiazepine, Depression, Depressive disorders, treatment-resistant, Mental health, Psychiatry, Public health
Référence
Prog Neuropsychopharmacol Biol Psychiatry. 2023 04 27;:110779